Yasasever V, Tas F, Duranyildiz D, Camlica H, Kurul S, Dalay N
Department of Basic Oncology, Oncology Institute, Capa, Istanbul, 34390, Turkey.
Pathol Oncol Res. 2000;6(1):42-5. doi: 10.1007/BF03032657.
The incidence of malignant melanoma has been steadily increasing over the past decades. CD 44 is a transmembrane glycoprotein which is implicated in a number of adhesive and migratory events. Downregulation of CD 44 is implicated in the metastatic process. P-Selectin is a member of the selectin family of cell surface molecules. The levels of P-Selectin in biological fluids may be elevated in subjects with a variety of pathological conditions. In malignant melanoma, elevation of the plasma level of soluble intercellular adhesion molecule-1 (sICAM-1) has been associated with a reduction in disease-free survival. This study was performed to investigate the differences in the serum concentrations of the adhesion molecules in patients with malignant melanoma. The study group consisted of 52 patients with malignant melanoma and 20 healthy subjects. No meaningful difference was observed for P-selectin and sICAM 1 levels. A statistically significant decrease was observed in the cancer patients for serum CD 44 levels.
在过去几十年中,恶性黑色素瘤的发病率一直在稳步上升。CD44是一种跨膜糖蛋白,参与多种黏附与迁移过程。CD44的下调与转移过程有关。P-选择素是细胞表面分子选择素家族的一员。在患有多种病理状况的受试者中,生物体液中P-选择素的水平可能会升高。在恶性黑色素瘤中,可溶性细胞间黏附分子-1(sICAM-1)血浆水平的升高与无病生存期的缩短有关。本研究旨在调查恶性黑色素瘤患者血清中黏附分子浓度的差异。研究组由52例恶性黑色素瘤患者和20名健康受试者组成。P-选择素和sICAM-1水平未观察到有意义的差异。癌症患者血清CD44水平出现了统计学上的显著下降。